Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 197

1.

AIDS-related cancers in the era of highly active antiretroviral therapy.

Biggar RJ.

Oncology (Williston Park). 2001 Apr;15(4):439-48; discussion 448-9. Review.

2.

AIDS malignancies in the era of highly active antiretroviral therapy.

Gates AE, Kaplan LD.

Oncology (Williston Park). 2002 Apr;16(4):441-51, 456, 459. Review.

3.

Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults.

International Collaboration on HIV and Cancer..

J Natl Cancer Inst. 2000 Nov 15;92(22):1823-30.

PMID:
11078759
4.

AIDS-related malignancies: emerging challenges in the era of highly active antiretroviral therapy.

Cheung MC, Pantanowitz L, Dezube BJ.

Oncologist. 2005 Jun-Jul;10(6):412-26. Review.

5.

AIDS malignancies in the era of highly active antiretroviral therapy.

Gates AE, Kaplan LD.

Oncology (Williston Park). 2002 May;16(5):657-65; discussion 665, 668-70. Review.

6.

[Epidemiology of HIV-associated malignancies].

Launay O, Guillevin L.

Bull Cancer. 2003 May;90(5):387-92. Review. French.

7.

The epidemiology of acquired immunodeficiency syndrome malignancies.

Goedert JJ.

Semin Oncol. 2000 Aug;27(4):390-401. Review.

PMID:
10950365
8.

Less cancer--or more--with HAART? Or, reflections on a late opus.

Mascolini M.

J Int Assoc Physicians AIDS Care. 1998 Jun;4(6):12-22.

PMID:
11365531
9.

Risk of other cancers following Kaposi's sarcoma: relation to acquired immunodeficiency syndrome.

Biggar RJ, Curtis RE, Cote TR, Rabkin CS, Melbye M.

Am J Epidemiol. 1994 Feb 15;139(4):362-8.

PMID:
8109570
10.

AIDS-related cancer and severity of immunosuppression in persons with AIDS.

Biggar RJ, Chaturvedi AK, Goedert JJ, Engels EA; HIV/AIDS Cancer Match Study..

J Natl Cancer Inst. 2007 Jun 20;99(12):962-72. Epub 2007 Jun 12.

PMID:
17565153
11.

The epidemiology of AIDS--related neoplasms.

Biggar RJ, Rabkin CS.

Hematol Oncol Clin North Am. 1996 Oct;10(5):997-1010. Review.

PMID:
8880192
12.

Assessing the impact of HAART on the incidence of defining and non-defining AIDS cancers among patients with HIV/AIDS: a systematic review.

Cobucci RN, Lima PH, de Souza PC, Costa VV, Cornetta Mda C, Fernandes JV, Gonçalves AK.

J Infect Public Health. 2015 Jan-Feb;8(1):1-10. doi: 10.1016/j.jiph.2014.08.003. Epub 2014 Oct 5. Review.

13.
14.
15.

Trends in Kaposi's sarcoma and non-Hodgkin's lymphoma incidence in the United States from 1973 through 1998.

Eltom MA, Jemal A, Mbulaiteye SM, Devesa SS, Biggar RJ.

J Natl Cancer Inst. 2002 Aug 21;94(16):1204-10.

PMID:
12189223
16.

[AIDS associated cancers in the era of highly active antiretroviral therapy (HAART)].

Tserenpuntsag B, Kołacińska A, Jabłonowska E.

Przegl Epidemiol. 2007;61(3):529-34. Review. Polish.

PMID:
18069390
17.

Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.

Clifford GM, Polesel J, Rickenbach M, Dal Maso L, Keiser O, Kofler A, Rapiti E, Levi F, Jundt G, Fisch T, Bordoni A, De Weck D, Franceschi S; Swiss HIV Cohort..

J Natl Cancer Inst. 2005 Mar 16;97(6):425-32.

PMID:
15770006
18.

AIDS-related malignancies: changing epidemiology and the impact of highly active antiretroviral therapy.

Bower M, Palmieri C, Dhillon T.

Curr Opin Infect Dis. 2006 Feb;19(1):14-9. Review.

PMID:
16374212
19.

Spectrum of cancer risk late after AIDS onset in the United States.

Simard EP, Pfeiffer RM, Engels EA.

Arch Intern Med. 2010 Aug 9;170(15):1337-45. doi: 10.1001/archinternmed.2010.253.

20.

Epidemiology of AIDS-related malignancies an international perspective.

Mbulaiteye SM, Parkin DM, Rabkin CS.

Hematol Oncol Clin North Am. 2003 Jun;17(3):673-96, v. Review.

PMID:
12852650

Supplemental Content

Support Center